Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Cardiovascular Medicine›Cerebral Infarction
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Cerebral Infarction

Cardiovascular Medicine · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

The formation of an area of necrosis in the cerebrum caused by an insufficiency of arterial or venous blood flow.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (961 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The formation of an area of necrosis in the cerebrum caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., infarction, anterior cerebral artery), and etiology (e.g., embolic infarction).

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Cerebral Infarctions; Infarctions, Cerebral; Cerebral Infarct; Cerebral Infarcts; Infarct, Cerebral; Infarcts, Cerebral; Infarction, Cerebral; Anterior Choroidal Artery Infarction.

Where it fits in the MeSH classification

Broader topics
Brain Infarction
Narrower topics
CADASIL; Dementia, Multi-Infarct; Infarction, Anterior Cerebral Artery; Infarction, Middle Cerebral Artery; Infarction, Posterior Cerebral Artery

Related concepts

  • Necrosis
  • Cerebrum
  • Infarction
  • Anterior Cerebral Artery

Research landscape

PubMed indexes 40,068 records tagged with the MeSH heading “Cerebral Infarction” (counts retrieved 2026-10-29). 7,792 of them (19.4%) were published from 2020 onward, and the busiest period so far is through 1999 with 11,885 records.

Reviews account for 2,840 records (7.1%) and meta-analyses for 242. Randomized controlled trials number 728 (1.8%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 11,885 records; 2000-2009: 9,796 records; 2010-2019: 10,595 records; 2020 onward: 7,792 records11,885through 19999,7962000-200910,5952010-20197,7922020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199911,885
2000-20099,796
2010-201910,595
2020 onward7,792
Share of records by publication typeReviews: 7.1 percent; Meta-analyses: 0.6 percent; Randomized controlled trials: 1.8 percentReviews7.1% (2,840)Meta-analyses0.6% (242)Randomized controlled trials1.8% (728)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 40,068 PubMed records
TypeRecordsShare
Reviews2,8407.1%
Meta-analyses2420.6%
Randomized controlled trials7281.8%

Method: PubMed query "Cerebral Infarction"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in cardiovascular medicine

Cardiovascular medicine has an unusually large body of randomized trials, so the type of outcome matters: hard clinical events such as death, heart attack and stroke carry more weight than changes in blood pressure, cholesterol or imaging markers that only predict risk. Observational studies can show associations but are confounded by age, lifestyle and other illness. Check whether a result is about prevention or treatment, the baseline risk of participants, and the absolute rather than only the relative size of any benefit.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Reduced myelin contributes to cognitive impairment in patients with monogenic small vessel disease
Denecke J, Dewenter A, Lee J, Franzmeier N, Valentim C, Kopczak A, et al.
2025Research article
Design not recorded in structured metadata
8cc by
PMID 40317599 · DOI · PMC12046978
Local arterial administration of acidified malonate as an adjunct therapy to mechanical thrombectomy in ischemic stroke
Lee JJ, Prag HA, Chary K, Abe J, Uno S, Sorby-Adams A, et al.
2025Research article
Design not recorded in structured metadata
6cc by
PMID 40577592 · DOI · PMC12352302
Synergistic effect between cortical cerebral microinfarcts and brain atrophy on cognitive decline
Huang J, Tan WY, Cui J, On SH, Chong EJY, Chen C, et al.
2025Research article
Design not recorded in structured metadata
5cc by
PMID 40796328 · DOI · PMC12588707
Small vessel dysfunction at 7T MRI locally predicts white matter damage progression in CADASIL
Pham SD, van den Brink H, Kopczak A, Vlegels N, De Luca A, Gesierich B, et al.
2026Research article
Design not recorded in structured metadata
4cc by
PMID 40832975 · DOI · PMC12367715

Reduced myelin contributes to cognitive impairment in patients with monogenic small vessel disease [1]

Research article Denecke J, Dewenter A, Lee J, Franzmeier N, Valentim C, Kopczak A, et al. · · 2025 · cited 8 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
IntroductionMyelin is pivotal for signal transfer and thus cognition.
Closing excerpt
Alterations in χ-negative values made a unique contribution to explain processing speed impairment, even when controlled for diffusion and iron changes.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (240 words)

IntroductionMyelin is pivotal for signal transfer and thus cognition. Cerebral small vessel disease (cSVD) is primarily associated with white matter (WM) lesions and diffusion changes; however, myelin alterations and related cognitive impairments in cSVD remain unclear.MethodsWe included 64 patients with familial cSVD (i.e., cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy [CADASIL]) and 20 cognitively unimpaired individuals. χ separation applied to susceptibility weighted imaging was used to assess myelin and iron within WM hyperintensities, normal appearing WM, and two strategic fiber tracts. Diffusion-based mean diffusivity and free water were analyzed for comparisons. Cognitive impairment was assessed by the Trail Making Test.ResultsCADASIL patients showed reduced myelin within WM hyperintensities and its penumbra in the normal appearing WM. Myelin was moderately correlated with diffusion and iron changes and associated with slower processing speed controlled for diffusion and iron alterations.DiscussionMyelin constitutes WM alterations distinct from diffusion changes and substantially contributes to explaining cognitive impairment in cSVD.Highlightsχ-negative magnetic resonance signal was reduced within white matter hyperintensities and normal appearing white matter in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, suggesting widespread myelin decreases due to cerebral small vessel disease (cSVD). χ-negative values were only moderately associated with diffusion tensor imaging derived indices including free water and mean diffusivity, suggesting that χ separation depicts distinct microstructural changes in cSVD. Alterations in χ-negative values made a unique contribution to explain processing speed impairment, even when controlled for diffusion and iron changes.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40317599 · DOI · PMC12046978

Local arterial administration of acidified malonate as an adjunct therapy to mechanical thrombectomy in ischemic stroke [2]

Research article Lee JJ, Prag HA, Chary K, Abe J, Uno S, Sorby-Adams A, et al. · · 2025 · cited 6 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
AimsIschemic stroke is increasingly treated by mechanical thrombectomy (MT) with the more rapid and complete reperfusion of the ischemic tissue, enhancing patient outcome, compared to recombinant tissue plasminogen activator (rtPA) alone.
Closing excerpt
ConclusionThese findings suggest aDSM as a potential adjunct therapy to further improve outcomes for stroke patients treated by MT.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (152 words)

AimsIschemic stroke is increasingly treated by mechanical thrombectomy (MT) with the more rapid and complete reperfusion of the ischemic tissue, enhancing patient outcome, compared to recombinant tissue plasminogen activator (rtPA) alone. Even so, there is still extensive brain infarction and disability following MT, which is exacerbated by ischemia-reperfusion injury (IRI) and other pathological processes during reperfusion. Hence, an adjunct therapy to MT that decreases IRI should enhance patient outcomes.Methods and resultsTo test this possibility, we adapted the transient middle cerebral artery occlusion (tMCAO) mouse model to allow local intra-arterial administration of acidified disodium malonate (aDSM) to decrease IRI as the ischemic tissue was reperfused. Administration of aDSM (160 mg/kg; pH 6) during reperfusion decreased brain infarct volume by ∼60% when assessed by magnetic resonance imaging (MRI) 24 h after reperfusion and improved neurological function.ConclusionThese findings suggest aDSM as a potential adjunct therapy to further improve outcomes for stroke patients treated by MT.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40577592 · DOI · PMC12352302

Synergistic effect between cortical cerebral microinfarcts and brain atrophy on cognitive decline [3]

Research article Huang J, Tan WY, Cui J, On SH, Chong EJY, Chen C, et al. · · 2025 · cited 5 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Cortical cerebral microinfarcts are associated with brain atrophy in cross-sectional studies, with further investigation using longitudinal datasets being warranted.
Closing excerpt
These findings highlight the importance of investigating the role of mixed pathologies in the development of cognitive impairment and dementia in future research.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (368 words)

Cortical cerebral microinfarcts are associated with brain atrophy in cross-sectional studies, with further investigation using longitudinal datasets being warranted. Moreover, little is known about their combined impact on cognition. This study aimed to establish the association between cortical cerebral microinfarcts and brain volume loss over time and explore whether they synergistically contribute to cognitive decline. A total of 475 patients, aged 72.7 ± 7.9 years, were enrolled from a memory clinic cohort, who underwent neuroimaging and neuropsychological assessments at least twice over 5 years. Cortical cerebral microinfarcts and other cerebrovascular disease were assessed using 3-T MRI. Brain volumes were calculated semi-automatically using FreeSurfer. Cognitive function was assessed using a neuropsychological test battery including six domains. Linear mixed-effect models were utilized to examine the association between cortical cerebral microinfarcts and brain volume loss and their interaction on cognitive decline. Estimated marginal means were derived to plot global cognitive trajectories. Cortical cerebral microinfarcts were associated with a greater decrease over 2 years in total brain volume [β = -1.94 (-3.07, -0.82) at Year 2, P-interaction with time < 0.001], grey matter volume [β = -1.00 (-1.69, -0.30) at Year 2, P-interaction = 0.002] and white matter volume [β = -0.95 (-1.54, -0.35) at Year 2, P-interaction < 0.001]. Brain volume loss was more pronounced in patients with multiple microinfarcts. Patients with high brain volume loss and cortical cerebral microinfarcts, particularly multiple microinfarcts, exhibited significantly lower global cognitive scores [single microinfarct: β = -1.83 (-2.68, -0.97) at Year 5, P-interaction with time < 0.001; multiple microinfarcts: β = -3.13 (-4.21, -2.05) at Year 5, P-interaction < 0.001]. The synergistic effects were more significant in the domains of executive function, memory, language and visuospatial function. Global cognitive trajectories revealed greater cognitive decline in patients with high brain volume loss and single or multiple microinfarcts, with the latter showing the steepest slope. This study established a longitudinal association between cortical cerebral microinfarcts and brain atrophy progression, with higher microinfarct burden associated with more pronounced brain volume loss. Furthermore, cortical cerebral microinfarcts and brain atrophy showed synergistic effects on cognitive decline. These findings highlight the importance of investigating the role of mixed pathologies in the development of cognitive impairment and dementia in future research.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40796328 · DOI · PMC12588707

Small vessel dysfunction at 7T MRI locally predicts white matter damage progression in CADASIL [4]

Research article Pham SD, van den Brink H, Kopczak A, Vlegels N, De Luca A, Gesierich B, et al. · · 2026 · cited 4 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Cerebral small vessel diseases (cSVDs) contribute significantly to stroke and dementia.
Closing excerpt
These findings suggest that local vascular function plays a key role in white matter damage progression in CADASIL, highlighting the importance of regional vascular health in cSVDs.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (201 words)

Cerebral small vessel diseases (cSVDs) contribute significantly to stroke and dementia. Advanced 7 T MRI techniques have revealed small vessel dysfunction in cSVD patients, linked to global white matter damage cross-sectionally. However, it remains unclear whether these vascular deficits predict progressive tissue damage. This longitudinal study examined the spatial relationship between local vascular function and white matter damage progression in patients with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). Twenty-two patients underwent baseline small vessel function assessment using 7 T MRI. Voxelwise blood-oxygenation level-dependent cerebrovascular reactivity (BOLD-CVR) to a hypercapnic was evaluated. White matter changes were assessed on 3 T MRI over two years, analyzing mean diffusivity changes and conversion of normal-appearing white matter to white matter hyperintensities (WMH). Results showed significant global increases in white matter damage over time. Voxelwise analysis revealed that lower baseline BOLD-CVR magnitude and higher dispersion were associated with increased white matter damage and WMH progression at specific locations at follow-up. However, whole-brain vascular function measures did not predict white matter changes at a global level. These findings suggest that local vascular function plays a key role in white matter damage progression in CADASIL, highlighting the importance of regional vascular health in cSVDs.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40832975 · DOI · PMC12367715

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review) [5]
    Zhao Y, Zhang X, Chen X, Wei Y · Int J Mol Med · 2022 · cited 453 times (Europe PMC)
  • Research article Detection, risk factors, and functional consequences of cerebral microinfarcts [6]
    van Veluw SJ, Shih AY, Smith EE, Chen C, Schneider JA, Wardlaw JM, et al. · Lancet Neurol · 2017 · cited 251 times (Europe PMC)
  • Research article Efficacy of endovascular thrombectomy in patients with M2 segment middle cerebral artery occlusions: meta-analysis of data from the HERMES Collaboration [7]
    Menon BK, Hill MD, Davalos A, Roos YBWEM, Campbell BCV, Dippel DWJ, et al. · J Neurointerv Surg · 2019 · cited 246 times (Europe PMC)
  • Research article Cerebral microinfarcts: a systematic review of neuropathological studies [8]
    Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ · J Cereb Blood Flow Metab · 2012 · cited 203 times (Europe PMC)
  • Research article Cardiovascular and neurological causes of sudden death after ischaemic stroke [9]
    Sörös P, Hachinski V · Lancet Neurol · 2012 · cited 184 times (Europe PMC)
  • Research article Poststroke depression: a review [10]
    Robinson RG, Spalletta G · Can J Psychiatry · 2010 · cited 183 times (Europe PMC)

References

  1. Denecke J, Dewenter A, Lee J, Franzmeier N, Valentim C, Kopczak A, et al.. Reduced myelin contributes to cognitive impairment in patients with monogenic small vessel disease. . 2025. PMID 40317599 · DOI · PMC12046978
  2. Lee JJ, Prag HA, Chary K, Abe J, Uno S, Sorby-Adams A, et al.. Local arterial administration of acidified malonate as an adjunct therapy to mechanical thrombectomy in ischemic stroke. . 2025. PMID 40577592 · DOI · PMC12352302
  3. Huang J, Tan WY, Cui J, On SH, Chong EJY, Chen C, et al.. Synergistic effect between cortical cerebral microinfarcts and brain atrophy on cognitive decline. . 2025. PMID 40796328 · DOI · PMC12588707
  4. Pham SD, van den Brink H, Kopczak A, Vlegels N, De Luca A, Gesierich B, et al.. Small vessel dysfunction at 7T MRI locally predicts white matter damage progression in CADASIL. . 2026. PMID 40832975 · DOI · PMC12367715
  5. Zhao Y, Zhang X, Chen X, Wei Y. Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review). Int J Mol Med. 2022. PMID 34878154 · DOI · PMC8711586
  6. van Veluw SJ, Shih AY, Smith EE, Chen C, Schneider JA, Wardlaw JM, et al.. Detection, risk factors, and functional consequences of cerebral microinfarcts. Lancet Neurol. 2017. PMID 28716371 · DOI · PMC5861500
  7. Menon BK, Hill MD, Davalos A, Roos YBWEM, Campbell BCV, Dippel DWJ, et al.. Efficacy of endovascular thrombectomy in patients with M2 segment middle cerebral artery occlusions: meta-analysis of data from the HERMES Collaboration. J Neurointerv Surg. 2019. PMID 30975736 · DOI
  8. Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ. Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab. 2012. PMID 22234334 · DOI · PMC3293128
  9. Sörös P, Hachinski V. Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol. 2012. PMID 22265213 · DOI
  10. Robinson RG, Spalletta G. Poststroke depression: a review. Can J Psychiatry. 2010. PMID 20540828 · DOI · PMC3647458

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Myocardial InfarctionCardiovascular Medicine
  • Brain IschemiaCardiovascular Medicine
  • ST Elevation Myocardial InfarctionCardiovascular Medicine
  • Cerebral HemorrhageCardiovascular Medicine
  • StrokeCardiovascular Medicine
  • Cerebral Amyloid AngiopathyCardiovascular Medicine

All 105 articles in Cardiovascular Medicine →

At a glance

40,068
PubMed records on this heading
19%
published since 2020
2,840
review articles
728
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Myocardial InfarctionCardiovascular Medicine
  • Brain IschemiaCardiovascular Medicine
  • ST Elevation Myocardial InfarctionCardiovascular Medicine
  • Cerebral HemorrhageCardiovascular Medicine
  • StrokeCardiovascular Medicine

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support